Tina Copple
Family · San Antonio, TXNPI 1568676500
Payments from drug & device makers
Across 2,163 payments — averaging $44.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kyowa Kirin, Inc.$33K
- Radius Health, Inc.$5K
- Medtronic$5K
- Novo Nordisk$5K
- Bayer$5K
- AstraZeneca$4K
- plus $40K from 54 others
What the payments were for
- Consulting fees$4,8495%
- Speaking & faculty fees$26,71928%
- Travel & lodging$10,18911%
- Food & beverage$54,96157%
- Education$430%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CRYSVITA$13,722
- Kerendia$3,939
- Tymlos$3,762
- DEXCOM G6 TRANSMITTER$2,438
- iLet Bionic Pancreas$2,402
- FREESTYLE LIBRE 3$1,853
- FARXIGA$1,484
- NEXLETOL$1,393
- MINIMED 780G$1,220
- NEXLIZET$1,119
- LEQVIO$817
- INPEN SMART INSULIN DELIVERY SYSTEM$726
- TEPEZZA$695
- AFREZZA$632
- Korlym$605
- Ozempic$595
- MINIMED 770G$534
- Wegovy$506
- Strensiq$450
- CeQur Simplicity$430
How this compares
$96,760 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 619 | $715,584 |
| OzempicSemaglutide | 499 | $711,064 |
| JardianceEmpagliflozin | 224 | $329,405 |
| TrulicityDulaglutide | 199 | $278,693 |
| FarxigaDapagliflozin Propanediol | 179 | $214,932 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 149 | $173,180 |
| AfrezzaInsulin Regular, Human | 58 | $149,946 |
| Humalog Kwikpen U-200Insulin Lispro | 31 | $130,714 |
| Somatuline DepotLanreotide Acetate | 11 | $107,764 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 74 | $102,943 |
| TymlosAbaloparatide | 27 | $91,371 |
| ProliaDenosumab | 48 | $81,503 |
| Tresiba Flextouch U-100Insulin Degludec | 106 | $73,827 |
| Repatha SureclickEvolocumab | 77 | $63,161 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 33 | $54,358 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Lyumjev, Forteo, Humalog | $2,548 | $1,114,770930 claims |
| Novo NordiskOzempic, Fiasp, Rybelsus, Novolog | $4,903 | $799,572596 claims |
| Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta | $1,573 | $402,149275 claims |
| AstraZenecaFarxiga | $3,984 | $214,932179 claims |
| Mannkind CorporationAfrezza | $2,722 | $149,94658 claims |
| Ipsen Biopharmaceuticals, IncSomatuline Depot | $48 | $107,76411 claims |
| Radius Health, Inc.Tymlos | $5,497 | $91,37127 claims |
| AmgenProlia | $2,466 | $81,50348 claims |
| MerckJanuvia, Janumet Xr | $110 | $45,99640 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 15,456 family providers in Texas.
Other family in San Antonio
- Anna CastroSan Antonio$184K
- Natalia FariasSan Antonio$124K
- Ayoade AvworoSan Antonio$111K
- Kim HinojosaSan Antonio$63K
- Kimberly GibergaSan Antonio$36K
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.